Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07324200

Objective Assessment of Intraocular Lens Tilt and Decentration

Prospective, multi-center, non-interventional, open label, randomized clinical study.

Recruiting

Interested in participating?

Request Info

Key information

Age range

22 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Empire Eye & Laser Center, Bakersfield, California, United States

Loading trial locations.

About this study

The objective of this study is to evaluate the repeatability and reproducibility (R&R) of a method based on Optical Coherence Tomography (OCT) image analysis for assessing IOL tilt and decentration in patients unilaterally or bilaterally implanted with TECNIS refractive or diffractive non-toric IOL models.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(ALL CRITERIA APPLY TO STUDY EYE)

  • Read, understand, and sign the informed consent and HIPAA authorization forms, and receive a fully executed copy of the signed forms.
  • Appear capable and willing to adhere to the clinical protocol instructions.
  • Be 22 years of age or older at the time of screening.
  • Have undergone unilateral or bilateral implantation with a desired non-toric TECNIS IOL design (e.g., refractive or diffractive).
  • At least three months postoperative in the eligible eye.

Exclusion criteria

(ALL CRITERIA APPLY TO STUDY EYE)

  • Any medical or ocular history, in the opinion of the investigator, that may impact study procedures such as ocular trauma, pseudoexfoliation syndrome, retinal pigment degeneration, macular pathology, glaucoma, retinal disease, corneal disease, or corneal opacities.
  • Have any condition that may affect the eye's ability to fixate (e.g., amblyopia).
  • Have a history of corneal or intraocular surgery other than cataract surgery.
  • Using ocular or systemic medications known to interact with dilation drops.
  • Have a history of allergic reactions to dilation drops.
  • Have clinically significant pupil abnormalities (e.g., non-reactive, fixed, or abnormally shaped pupils).
  • Has an intraocular pressure of ≥ 21mm Hg before mydriasis.
  • Have a mydriatic pupil diameter of less than 6 mm.
  • Have participated in a clinical trial within 7 days prior to study enrollment.
  • An employee (e.g., Investigator, Coordinator, or Technician) or immediate family member (including partner, child, parent, grandparent, grandchild, or sibling) of an employee of the clinical site or study sponsor.
  • Currently pregnant or lactating.

Treatment and study plan

OCT Imaging Test

Diagnostic Test

The primary objective of this study is to evaluate the repeatability and reproducibility (R&R) of a method based on Optical Coherence Tomography (OCT) image analysis for assessing IOL tilt and decentration in patients unilaterally or bilaterally implanted with TECNIS refractive or diffractive non-toric IOL models.

Other names: Basic Science

Primary outcomes

  1. Magnitude and Direction of IOL decentration and; Magnitude and Direction of IOL tilt.

    Time frame: One study visit

    The primary endpoints for this study will be:

    • Magnitude of IOL decentration relative to the visual axis through OCT (IOL Master 700) image analysis.
    • Direction of IOL decentration relative to the visual axis through OCT (IOL Master 700) image analysis.
    • Magnitude of IOL tilt relative to the visual axis through OCT (IOL Master 700) image analysis.
    • Direction of IOL tilt relative to the visual axis through OCT (IOL Master 700) image analysis.

Study contacts

Contact information is provided by the study sponsor or research team.

Kristen Leraas

CONTACT

[email protected]

Siddhesh Raorane

CONTACT

[email protected]

904-539-7205

Sponsors and collaborators

Lead sponsor

Johnson & Johnson Surgical Vision, Inc.

Industry

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jan 7, 2026
Registry last updated
May 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.